Digital Diabetes Project

A pilot study to test the usability and acceptability of virtual support for patients with type 1 diabetes in Highland region

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN57929056

Enrollment

Registered

2014-03-17

Start date

2013-10-01

Completion date

Unknown

Last updated

2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus

Interventions

The type of clinic that is proposed will enable the same functionality of a traditional diabetes clinic, but it will not require patients or staff to meet face-to-face. Phase 1 and 2 will develop a te

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 1 diabetes 2. Over 18 3. Glycosylated hemoglobin (HbA1c) > 64mmol/mol (8%) 4. Diabetes duration of more than 12 months 5. Access to the internet 6. Ability to give informed consent 7. Access to a personal computer (PC) or laptop with a webcam 8. Have an email address 9. Have a mobile phone

Exclusion criteria

Exclusion criteria: 1. Any form of diabetes other than type 1 2. Those on insulin pump therapy 3. HbA1c = 64mmol/mol (=8%) 4. Diabetes duration of less than 12 months 5. Those without access to a PC or laptop which includes a webcam 6. Those without internet access 7. Those without an email address 8. Those without a mobile phone 9. Unable to use a PC, mobile phone or email

Design outcomes

Primary

Measure	Time frame
To determine the usability and acceptability of a variety of digital communication modes between the specialist diabetes team and patients with diabetes. An elicitation questionnaire exploring patients' views on a digital diabetes clinic will be used in phase 1 of the study to develop an evaluation questionnaire to be piloted in phase 2 of the study. The method to be used to measure the outcomes for the main part of the study (phase 3) will be 3 questionnaires. There will be a self-efficacy for diabetes questionnaire, summary of diabetes self-care activities questionnaire and the evaluation questionnaire which has been validated in phase 1 and 2.	—

Measure

Time frame

To determine the usability and acceptability of a variety of digital communication modes between the specialist diabetes team and patients with diabetes. An elicitation questionnaire exploring patients' views on a digital diabetes clinic will be used in phase 1 of the study to develop an evaluation questionnaire to be piloted in phase 2 of the study. The method to be used to measure the outcomes for the main part of the study (phase 3) will be 3 questionnaires. There will be a self-efficacy for diabetes questionnaire, summary of diabetes self-care activities questionnaire and the evaluation questionnaire which has been validated in phase 1 and 2.

—

Secondary

Measure	Time frame
To determine if secure, reliable methods can be established for sharing blood glucose data and for assimilating different modes of communication into patient records in addition to assessment of change in glycaemia control.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026